Where I see patients (1)
My reviews
4.9
Selected research
-
The metabolic potential of the paediatric-onset multiple sclerosis gut microbiome.
Multiple sclerosis and related disorders
-
Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS".
Annals of neurology
-
Stability of the gut microbiota in persons with paediatric-onset multiple sclerosis and related demyelinating diseases.
Multiple sclerosis (Houndmills, Basingstoke, England)
Clinical trials
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
NEP is defined as no progression sustained for at least 24 weeks on all of the following three components (confirmed disability progression [CDP]; ≥20% increase in timed 25-foot walk test [T25FWT]; ≥20% increase in nine-hole peg t...
Recruiting
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Time to sustained disability progression is measured by the Expanded Disability Status Scale plus (EDSS+): a composite endpoint that includes EDSS change (change at any 6 month time point of > 1.0 point if baseline EDSS is < 5.5 o...
Recruiting